Search for: "PFIZER V APOTEX"
Results 81 - 100
of 211
Sorted by Relevance
|
Sort by Date
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog)… [read post]
23 Jun 2010, 10:28 pm
Apotex, Inc. et al. [read post]
10 May 2007, 9:32 pm
Thus, to the extent that the change as to Deuel/O'Farrell becomes ingrained, the Supreme Court, by lowering the requirements for TSM, has made it easier to challenge patents.In this, IPBiz reminds readers of the Norvasc case (Pfizer v. [read post]
10 Nov 2011, 7:16 pm
Ltd. v. [read post]
28 Jun 2007, 9:19 pm
Teleflex, as well as the Federal Circuit's recent decision in Pfizer v. [read post]
28 May 2013, 5:30 am
Royal Bank issues supplier code of conduct after outsourcing backlash http://t.co/IkqEyAYBWF -> Sky apps targeted by Syrian hackers http://t.co/dkjfqhP7xm -> Google tells Federal Circuit what it actually likes about Judge Robart's FRAND rate ruling http://t.co/lElp55Av23 -> Report: EU Investigating Apple's Iphone Agreements with Mobile Operators http://t.co/cbB8DXbk3g -> The Next Big Bang in Kitchener-Waterloo http://t.co/HZgMpNqXEn -> User Generated Content Under Canadian Copyright… [read post]
30 Mar 2007, 1:05 pm
Pfizer. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Relpax (Eletripian hydrobromide) – Pfizer settles Relpax infringement suit with Apotex (Patent Docs) Solodyn (Minocycline) – US: Medicis and Lupin settle Solodyn infringement dispute; Agree to drug development collaboration (Patent Docs) Viagra (Sildenafil citrate) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
14 Dec 2006, 4:08 am
Apotex Corp., C.A. [read post]
28 Jul 2010, 12:06 am
Apotex Inc. et al. [read post]
21 Mar 2013, 10:11 am
See, e.g., Pfizer, Inc. v. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
21 Jun 2016, 4:00 am
Absent more definitive consistent instruction from the Federal Court of Appeal, or direct SCC pronouncement on the proper approach, patent drafters are still advised to keep their promises to a minimum to avoid disclosure challenges regarding sound prediction. _________________________ [1] Eli Lilly v Hospira 2016 FC 47 (Barnes) [2] Gilead v Idenix 2015 FC 1156 at para 381 (Annis), under appeal A-483-15, adopting earlier reasoning of Astra v Apotex 2014 FC 638… [read post]
2 Mar 2010, 5:10 am
Pfizer, Inc. v. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
2 Feb 2011, 3:52 am
: (Perhaps) only congress knows for sure (Patent Docs) US: More on data exclusivity (Patent Docs) US: BIO supports Patent Reform Act of 2011 (PatentlyBIOtech) US: President Obama proposes, BIO agrees (Patent Docs) US: Amicus briefs in AMP v USPTO: AARP (Patent Docs) US: Orphan drug designations and applications took off in 2010 while orphan drug approvals tapered off (FDA Law Blog) US: Dexcom wins major reexamination victories over Abbott (Reexamination Alert) Products Actonel (risedronate)… [read post]
6 Jul 2010, 5:18 am
" Pfizer Inc. et al v. [read post]
12 Sep 2007, 4:59 am
See Pfizer v. [read post]
14 May 2019, 11:24 am
Cir. 2009) (quoting Pfizer, Inc. v. [read post]
